Alternative pathway complement activation in rheumatoid arthritis
- PMID: 6158571
Alternative pathway complement activation in rheumatoid arthritis
Abstract
Serum and synovial fluid (SF) levels of the complement components C3, C5, factor B (B), properdin (P), beta 1H and C3b inactivator (C3bINA), and EDTA-plasma and SF concentrations of C3d and Ba were measured in 40 rheumatoid arthritis (RA) and 5 patients with osteoarthritis. Decreased SF concentration of B and P and increased levels of Ba showed that increased alternative pathway turnover occurred in RA. Reduced SF C3bINA concentrations occurred, but levels of beta 1H were not reduced. The results showed that alternative pathway turnover was dependent upon C3 turnover, but failed to support the notion that levels of C3bINA or beta 1H control alternative pathway turnover in RA.
Similar articles
-
Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.Clin Exp Immunol. 1979 Jun;36(3):408-14. Clin Exp Immunol. 1979. PMID: 114347 Free PMC article.
-
C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.J Clin Invest. 1976 Jun;57(6):1554-63. doi: 10.1172/JCI108426. J Clin Invest. 1976. PMID: 819459 Free PMC article.
-
Requirements for beta1H globulin and C3b inactivator in the control of the alternative complement pathway in human serum.Immunology. 1978 Dec;35(6):1045-9. Immunology. 1978. PMID: 83964 Free PMC article.
-
[Alternative complement pathway (author's transl)].Nouv Presse Med. 1979 Jun 9;8(26):2187-94. Nouv Presse Med. 1979. PMID: 382108 Review. French.
-
The human alternative complement pathway: biology and immunopathology of activation and regulation.Prog Allergy. 1982;30:193-234. Prog Allergy. 1982. PMID: 7041132 Review. No abstract available.
Cited by
-
Complement and autoimmunity.Immunol Res. 2013 Jul;56(2-3):477-91. doi: 10.1007/s12026-013-8422-y. Immunol Res. 2013. PMID: 23615835 Review.
-
Prognostic Value of Complement Properdin in Cancer.Front Immunol. 2021 Jan 19;11:614980. doi: 10.3389/fimmu.2020.614980. eCollection 2020. Front Immunol. 2021. PMID: 33542722 Free PMC article.
-
Properdin: A multifaceted molecule involved in inflammation and diseases.Mol Immunol. 2018 Oct;102:58-72. doi: 10.1016/j.molimm.2018.05.018. Epub 2018 Jun 27. Mol Immunol. 2018. PMID: 29954621 Free PMC article. Review.
-
The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.Clin Exp Immunol. 1982 Jun;48(3):726-32. Clin Exp Immunol. 1982. PMID: 6981475 Free PMC article.
-
Advantages of using complement components in preventive and therapeutic vaccine strategies for infectious and non-infectious diseases.J R Soc Interface. 2025 Jul;22(228):20250138. doi: 10.1098/rsif.2025.0138. Epub 2025 Jul 2. J R Soc Interface. 2025. PMID: 40592462 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous